A profile of SGLT-2 inhibitors in hyponatremia: The evidence to date-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A profile of SGLT-2 inhibitors in hyponatremia: The evidence to date

Published:2023-05 Issue: Volume:184 Page:106415
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Tang Hui,Xu Changjing,Zhang Piao,Luo Taimin,Huang Yilan,Yang Xuping

Funder

National Natural Science Foundation of China Shenzhen Robotics Research Center Project

National Natural Science Foundation of China

Southwest Medical University

The Affiliated Hospital of Southwest Medical University

Sichuan Province Science and Technology Support Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference150 articles.

1. Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression;Abdulrahman;Mol. Cell. Biochem.,2022

2. The prognosis of heart failure patients: does sodium level play a significant role?;Abebe;PLoS One,2018

3. Diagnosis and management of hyponatremia: a review;Adrogue;JAMA,2022

4. Clinica l practice guideline on diagnosis and treatment of hyponatraemia;Allolio;Intensive Care Med.,2014

5. Prognostic role of hyponatremia in heart failure patients depending on renal disease;Arevalo-Lorido;Clin. Evid. Cardiol.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23);Expert Opinion on Therapeutic Patents;2024-08-02

2. Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches;Biomedicines;2024-03-03

3. Konsensusempfehlungen zur Diagnose und Therapie der Hyponatriämie der Österreichischen Gesellschaft für Nephrologie 2024;Wiener klinische Wochenschrift;2024-02

4. Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study);Journal of Diabetology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3